Search

Search Constraints

You searched for: Author/Creator Pakseresht, Arash

Search Results

1. Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study. Issue 5 (11th July 2019)

2. Real-world clinical effectiveness of liraglutide 3.0 mg for weight management in Canada. Issue 3 (May 2019)

4. Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program. (15th April 2020)

6. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Issue 10278 (13th March 2021)

7. Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada. (9th May 2020)